CJC-1295 + GHRP-6: The Appetite-Enhanced GH Stack
CJC-1295
GHRH analogue - stimulates pituitary GH synthesis and pulsatile release for sustained elevation
GHRP-6
Ghrelin mimetic - triggers acute GH release with notable appetite stimulation (orexigenic effects)
The combination of CJC-1295 and GHRP-6 represents a potent growth hormone optimization stack designed for those seeking maximum GH release alongside significant appetite stimulation. This pairing exploits the same synergistic GHRH + GHRP mechanism as the CJC-1295/Ipamorelin stack, but with GHRP-6's unique orexigenic (hunger-promoting) properties.
GHRP-6 (Growth Hormone Releasing Peptide-6) is a hexapeptide ghrelin mimetic that triggers robust GH release while also significantly increasing appetite—an effect many consider either a benefit or drawback depending on their goals. When combined with CJC-1295's sustained GHRH signalling, this stack may produce substantial GH elevation with the added benefit of enhanced caloric intake capacity.
This combination is particularly relevant for research into muscle growth, recovery, and situations where increased appetite supports the goal (e.g., muscle building, recovery from illness or surgery, addressing poor appetite). For those seeking GH benefits without appetite stimulation, the CJC-1295 + Ipamorelin stack may be more appropriate.
**Critical Disclaimer:** Neither CJC-1295 nor GHRP-6 is approved for human therapeutic use by any regulatory authority including the MHRA, EMA, or FDA. Both are prohibited by WADA in sport. This content is for educational and research purposes only. Any use should only occur under qualified medical supervision within appropriate legal frameworks.
Synergistic Mechanism
The GHRH + GHRP Synergy with Appetite Enhancement
This stack operates through the same fundamental synergy as other GHRH/GHRP combinations, with the added dimension of GHRP-6's potent ghrelin-like effects on appetite.
How CJC-1295 Works
CJC-1295 (also known as Mod GRF 1-29 in its non-DAC form) is a modified analogue of growth hormone-releasing hormone (GHRH). It works by:
1. Stimulating GH Synthesis
- Binds to GHRH receptors on pituitary somatotrophs
- Increases transcription and production of growth hormone
- Creates a "loaded" state ready for GH release
2. Promoting Pulsatile Release
- Triggers coordinated GH secretion pulses
- The non-DAC version maintains physiological pulsatility
- Works with natural GH rhythm rather than overriding it
3. Extended Half-Life
- Modified amino acids resist enzymatic degradation
- Half-life of ~30 minutes (Mod GRF 1-29)
- DAC version extends to ~8 days but may blunt pulsatility
How GHRP-6 Works
GHRP-6 (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) is a synthetic hexapeptide that mimics ghrelin, the "hunger hormone."
1. Ghrelin Receptor Activation
- Binds to growth hormone secretagogue receptor (GHS-R1a)
- Triggers immediate GH release from stored pools
- Activates the ghrelin receptor pathway
2. Strong Appetite Stimulation
- Potent orexigenic effect via hypothalamic pathways
- Increases ghrelin-like signalling for hunger
- Peak hunger typically 20-30 minutes post-administration
- Most pronounced appetite effect of all GHRPs
3. GH Release Characteristics
- Produces rapid, robust GH pulse
- Peak GH levels at 15-30 minutes post-injection
- Significant cortisol and prolactin elevation (unlike Ipamorelin)
- Higher absolute GH release than more selective GHRPs
4. Additional Effects
- Increases gastric motility
- May enhance ghrelin-related metabolic signalling
- Potential effects on glucose metabolism
The Synergistic Mechanism
| Pathway | CJC-1295 Effect | GHRP-6 Effect | Combined Result |
|---------|-----------------|---------------|-----------------|
| GH Synthesis | ↑↑↑ Increases production | Minimal direct effect | Maximum GH availability |
| GH Release | ↑↑ Promotes release | ↑↑↑ Triggers acute release | Amplified GH pulses |
| Receptor | GHRH receptor | GHS-R1a (ghrelin) | Dual pathway activation |
| Duration | Sustained signalling | Acute burst | Extended elevated response |
| Appetite | Neutral | ↑↑↑ Strong increase | Significant hunger |
| Cortisol | Neutral | ↑ Moderate increase | Some elevation |
| Prolactin | Neutral | ↑ Moderate increase | Some elevation |
Synergy Magnitude:
Research suggests GHRH + GHRP combinations produce GH responses 5-10 times greater than either peptide alone. GHRP-6 may produce higher absolute GH levels than Ipamorelin, but with less selectivity (more cortisol/prolactin elevation).
Research Evidence
Research Evidence
CJC-1295 Research
Phase I Clinical Trial (2006):
- Examined CJC-1295 in healthy adults
- Single doses increased GH and IGF-1 significantly
- Effects persisted for 6+ days with DAC version
- Established proof-of-concept for GHRH analogue approach
GH Pulsatility Studies:
- Mod GRF 1-29 maintains physiological GH pulsatility
- 2-3 fold increase in GH pulse amplitude
- Preserves natural circadian rhythm
GHRP-6 Research
Early GH Secretagogue Research (1980s-1990s):
- GHRP-6 was one of the first synthetic GH secretagogues developed
- Demonstrated robust GH release in humans
- Established the therapeutic potential of ghrelin-pathway activation
Comparative GHRP Studies:
- GHRP-6 produces among the highest GH responses of the GHRP family
- More potent than GHRP-2 for raw GH output
- Significantly higher appetite stimulation than Ipamorelin or Hexarelin
- Notable cortisol and prolactin elevation compared to Ipamorelin
Appetite Mechanism Studies:
- GHRP-6 activates hypothalamic feeding centres
- Peak orexigenic effect at 20-30 minutes post-administration
- Mechanism involves neuropeptide Y and agouti-related peptide pathways
- Effect is dose-dependent and reproducible
Cardioprotective Research:
- GHRP-6 has shown cardioprotective effects in animal models
- Reduces infarct size in ischaemia-reperfusion studies
- May protect against oxidative cardiac damage
- Independent of GH release (direct cardiac effects)
Combination Studies
GHRH + GHRP Synergy (Bowers et al.):
- Demonstrated that combining GHRH analogues with GHRPs produces synergistic GH release
- Dual receptor activation amplifies response beyond additive effects
- Established the scientific basis for combination protocols
Theoretical Combination Benefits
Why CJC-1295 + GHRP-6:
| Aspect | CJC-1295 Contribution | GHRP-6 Contribution |
|--------|----------------------|---------------------|
| GH Production | Increases synthesis | Triggers release of stored GH |
| GH Magnitude | Sustained elevation | High acute pulse |
| Receptor Pathway | GHRH receptor | Ghrelin (GHS-R1a) receptor |
| Appetite | Neutral | Strong stimulation |
| Best For | Sustained GH support | Those wanting appetite boost |
Potential Combined Outcomes:
- Maximum GH release through dual pathways
- Enhanced appetite supporting caloric intake goals
- Superior muscle growth and recovery potential
- May benefit those with poor appetite or needing caloric surplus
Theoretical Protocol
Theoretical Protocol for GH Optimization with Appetite Enhancement
**⚠️ Research Disclaimer:** The following represents theoretical research parameters extrapolated from preclinical and limited clinical data. Neither peptide is approved for human therapeutic use. This is NOT medical advice.
Dosing Considerations
CJC-1295 (Mod GRF 1-29 - No DAC):
Typical Research Doses:
- 100-300 mcg per administration
- Most commonly 100 mcg when combined with GHRP-6
- Administered via subcutaneous injection
Rationale for No-DAC Version:
- Maintains natural GH pulsatility
- Synergises better with acute GHRP-6 pulses
- Avoids potential issues from continuous GH elevation
GHRP-6:
Typical Research Doses:
- 100-200 mcg per administration
- Commonly 100-150 mcg when in combination
- Higher doses increase appetite effect but diminishing GH returns
Dose-Response Considerations:
- GH response plateaus around 100-150 mcg
- Appetite stimulation continues increasing with dose
- Side effects (cortisol/prolactin) increase at higher doses
Combined Protocol Approaches
Standard Research Protocol:
- CJC-1295: 100 mcg
- GHRP-6: 100-150 mcg
- Mixed in same syringe or administered sequentially
- Subcutaneous injection
Frequency:
- 1-3 times daily
- Common protocols: upon waking, pre-workout, and/or before bed
- Pre-meal timing can leverage appetite enhancement
Duration:
- Research cycles typically 8-16 weeks
- Some protocols suggest periodic breaks (e.g., 5 days on, 2 days off)
- Long-term use not well characterised
CJC-1295 with DAC + GHRP-6
Less commonly combined due to:
- DAC version produces continuous rather than pulsatile release
- May reduce synergistic effect with acute GHRP-6 pulses
- Some protocols use weekly DAC with daily GHRP-6
Administration Considerations
Reconstitution:
- Bacteriostatic water is standard
- Store refrigerated after reconstitution
- Typically stable for 3-4 weeks refrigerated
Injection:
- Subcutaneous injection (abdomen, thigh)
- Some protocols suggest intramuscular
Timing Relative to Food:
- Administered on empty stomach for maximum GH response
- Fat and carbohydrates blunt GH response
- Wait 30 minutes before eating
- However, GHRP-6's appetite effect may make fasting challenging
Leveraging Appetite Stimulation:
- Pre-meal administration: Use the appetite boost to consume larger meals
- Muscle building protocols often time injections 30 min before planned large meals
- Post-workout + pre-meal timing supports both GH and nutrition goals
⚠️ **These are theoretical research extrapolations. No approved human protocols exist.**
Timing & Scheduling
Optimal Timing for Muscle Growth and Recovery
Strategic Timing Approaches
Unlike the CJC-1295/Ipamorelin stack often used for sleep, the CJC-1295/GHRP-6 combination is frequently timed around meals and training due to its appetite-enhancing properties.
Training-Centred Protocol
Post-Workout Administration:
- Administered within 30 minutes of completing training
- Takes advantage of exercise-enhanced GH sensitivity
- Appetite boost supports post-workout nutrition
- GH elevation during the recovery window
Reasoning:
- Exercise naturally elevates GH
- Exogenous GHRH + GHRP may amplify this response
- Enhanced appetite facilitates post-workout meal consumption
- Protein synthesis is elevated for several hours post-exercise
Meal-Centred Protocol
Pre-Meal Administration:
- Administered 20-30 minutes before planned large meals
- Leverages GHRP-6's peak appetite effect
- Particularly useful for those struggling to consume sufficient calories
- Supports muscle-building caloric surplus
Timing Example:
- Morning: Upon waking (30 min before breakfast)
- Post-workout: Immediately after training (before PWO meal)
- Evening: 30 minutes before dinner
Sleep Considerations
Pre-Sleep Administration:
- Less commonly used with GHRP-6 than Ipamorelin
- The appetite stimulation may disrupt sleep
- Cortisol elevation is counterproductive for sleep quality
- If used before bed, some report vivid dreams
Alternative for Sleep Focus:
- Consider CJC-1295 + Ipamorelin if sleep optimization is the priority
- GHRP-6's cortisol elevation makes it less suitable for bedtime
Factors Affecting Response
Enhance GH Response:
- Fasted state (challenge with GHRP-6 appetite effect)
- Post-exercise
- Adequate sleep
- Lower body fat percentage
Blunt GH Response:
- High blood glucose / recent carbohydrates
- High-fat meals
- Chronic stress
- Sleep deprivation
- Ageing
Expected Outcomes
Theoretical Expected Outcomes
Based on GH physiology and research on individual peptides, the CJC-1295 + GHRP-6 combination may theoretically support:
Appetite Enhancement
Significant Hunger Increase:
- Most pronounced effect of this stack
- Peak hunger 20-30 minutes post-administration
- Supports achieving caloric surplus for muscle building
- Helpful for those with naturally low appetite
- May benefit recovery from illness or surgery requiring increased nutrition
Potential Downsides:
- May be problematic for those trying to limit caloric intake
- Could lead to overeating if not managed
- Not suitable for fat loss goals (consider Ipamorelin alternative)
Muscle Growth and Body Composition
Anabolic Support:
- GH promotes protein synthesis
- Enhanced recovery from resistance training
- May support lean mass gains when combined with training and nutrition
- Effects are modest compared to anabolic steroids
Fat Metabolism:
- GH promotes lipolysis
- However, increased appetite may offset fat loss benefits
- This stack is generally NOT used for fat loss goals
Recovery and Repair
Tissue Repair:
- GH supports connective tissue synthesis
- May accelerate recovery from training
- Potential benefits for injury healing research
- Enhanced recovery capacity between sessions
Sleep and Recovery:
- Less sleep-focused than Ipamorelin stacks
- GH still supports restorative processes
- Some users report vivid dreams
Strength and Performance
Indirect Performance Benefits:
- Better recovery = more effective training
- Enhanced nutrition capacity supports training
- GH supports connective tissue integrity
Important Caveats
- Individual responses vary significantly
- Benefits depend on training, nutrition, and recovery practices
- Appetite effect can be overwhelming for some
- Cortisol and prolactin elevation may have implications
- Not suitable for fat loss or appetite-restricted goals
- Long-term effects are not well-characterised
Safety Considerations
Safety Considerations
GHRP-6-Specific Concerns
Unlike the highly selective Ipamorelin, GHRP-6 has a broader effect profile:
Appetite Stimulation:
- Strong, sometimes overwhelming hunger
- May lead to unintended caloric excess
- Difficult to manage for those with eating disorder history
- Can be challenging for people on calorie-restricted protocols
Cortisol Elevation:
- GHRP-6 causes moderate cortisol increase
- Chronic cortisol elevation has negative health implications
- May impact sleep quality if administered before bed
- Could theoretically affect immune function
Prolactin Elevation:
- GHRP-6 increases prolactin levels
- Chronic prolactin elevation can cause:
- Decreased libido
- Potential gynecomastia in men (rare)
- Menstrual irregularities in women
- Less of a concern with periodic use
Known Effects of GH Elevation
Common:
- Water retention (typically transient)
- Joint stiffness or discomfort
- Carpal tunnel-like symptoms (from fluid retention)
- Numbness/tingling in extremities
- Mild increase in blood glucose
Rare/Dose-Dependent:
- Headaches
- Fatigue or lethargy
- Mood changes
Comparison: GHRP-6 vs Ipamorelin
| Effect | GHRP-6 | Ipamorelin |
|--------|--------|------------|
| GH Release | Higher | Moderate |
| Appetite | ↑↑↑ Strong | Minimal |
| Cortisol | ↑↑ Moderate | Neutral |
| Prolactin | ↑↑ Moderate | Neutral |
| Sleep Suitability | Lower | Higher |
| Selectivity | Lower | Higher |
When to Choose GHRP-6:
- Goal requires appetite enhancement
- Muscle building / weight gain focus
- Maximum GH output desired
- Not concerned about cortisol/prolactin
When to Choose Ipamorelin:
- Sleep optimization is priority
- Fat loss goals (avoid appetite stimulation)
- Cleaner side effect profile desired
- Long-term use intended
Contraindications (Theoretical)
- Active malignancy or history of certain cancers
- Diabetic retinopathy
- Pregnancy or breastfeeding
- Children and adolescents (open growth plates)
- Uncontrolled diabetes
- History of eating disorders (appetite stimulation)
- Prolactinoma or hyperprolactinaemia
Drug Interactions
- May affect insulin and diabetes medication requirements
- May interact with glucocorticoids
- Effects on thyroid function possible with chronic use
- Consider interactions with appetite suppressants
Regulatory Status
- **Not approved** for human therapeutic use anywhere
- **Prohibited** by WADA in all sports
- Legal status varies by country—often available for research purposes only
- Prescription required in many jurisdictions for any use
Frequently Asked Questions
Conclusion
Conclusion
The CJC-1295 + GHRP-6 combination represents a targeted approach to growth hormone optimization for those specifically seeking appetite enhancement alongside GH elevation. Unlike the cleaner CJC-1295 + Ipamorelin stack, this pairing trades selectivity for potency and orexigenic effects.
Ideal Research Applications:
- Muscle building protocols requiring caloric surplus
- Addressing poor appetite in research contexts
- Maximum GH release protocols
- Recovery research requiring nutritional support
Key Advantages of This Combination:
- Synergistic GH release (5-10x greater than single peptide)
- Potent appetite stimulation supporting caloric intake
- Higher absolute GH release than Ipamorelin-based stacks
- May support muscle growth and recovery research
Key Limitations and Trade-offs:
- Cortisol and prolactin elevation (unlike Ipamorelin)
- Not suitable for fat loss or calorie-restricted goals
- Less suitable for sleep optimization protocols
- More side effects than selective alternatives
- Neither peptide is approved for human use
- Prohibited in competitive sport
This stack suits specific research goals—namely, those where appetite enhancement is a feature rather than a bug. For most general GH optimization research, the CJC-1295 + Ipamorelin combination offers a cleaner profile. Anyone exploring these peptides should work with qualified healthcare providers within appropriate legal frameworks.
**For research sourcing and further information:** [Peptide Barn UK](https://www.peptidebarn.co.uk/)